ConductScience.org, home

Trial · NCT07887711

Comparative Study Between Proprioceptive Neuromuscular Facilitation and Post-facilitation Stretching in Text Neck Syndrome

NCT07887711, Not applicable, Not yet recruiting, Cairo University

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. Comparative Study Between Proprioceptive Neuromuscular Facilitation and Post-facilitation Stretching in Text Neck Syndrome. Trials, record NCT07887711. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07887711

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Comparative Study Between Proprioceptive Neuromuscular Facilitation and Post-facilitation Stretching in Text Neck Syndrome
NCT number
NCT07887711
Status
Not yet recruiting
Phases
Not applicable
Enrollment
51 participants, estimated
Lead sponsor
Cairo University
Conditions
Text Neck Syndrome
Interventions
Proprioceptive Neuromuscular Facilitation, Post-facilitation Stretching, traditional treatment
First posted
2026-10-21
Last updated
2026-10-21

Source ClinicalTrials.gov

Registered outcomes4

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
Primarycraniovertebral angleup to four weeks
craniovertebral angle will be measured by lateral photographe.A lateral photograph is taken at the level of the participant's shoulder using a digital camera placed at a fixed distance.The anatomical landmarks (tragus of the ear and C7 spinous process) are identified and marked either physically or digitally using posture analysis software.The craniovertebral angle is calculated as the angle between:A horizontal line passing through C7, andA line connecting C7 to the tragus.CVA \< 48-50°: Indicates forward head posture (FHP),CVA ≥ 50°: Suggests a normal or neutral head posture.
Primarycervical range of motionup to four weekscervical range of motion will be measured by cervical range of motion device
Secondarypain intesintyup to four weeks
Pain intensity will be assessed using the Visual Analogue Scale (VAS). The VAS is a 10-centimeter horizontal line anchored by two descriptors: "no pain" (0) and "worst pain imaginable" (10). Each participant will be instructed to place a vertical mark along the line indicating the intensity of their pain. The distance (in cm) from the "no pain" anchor to the participant's mark will be measured and recorded as the pain score (
Secondaryneck disabilityup to four weeks
The Neck Disability Index (NDI) is the most widely used and validated self-report questionnaire for assessing neck pain-related disability.Questions include activities of daily living, such as: personal care, lifting, reading, work, driving, sleeping, recreational activities, pain intensity, concentration and headache. Each question is measured on a scale from 0 (no disability) to 5.The total score will be obtained by summing the item scores, yielding a total range from 0 to 50.

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers0

The papers the trial lists on ClinicalTrials.gov.

None in this release.

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT07887711

GET https://conductscience.org/api/trials/v1/NCT07887711/registered